chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This vaccine was given before the nurse realized that the refrigerator thermometer was broken.  The vaccine's temperature had been out of range.  Pfizer was contacted and the remaining vaccine needed to be wasted.  The patient had to be notified that the dose she received was not valid and has to be repeated.  No side effects noted.
This spontaneous report as received from certified medical assistant referring an unspecified number of patients whom on an unknown date, were vaccinated with a dose of GARDASIL the reporter was unable to provide lot #/expiration dates and administrations dates for the vaccine. It was reported that the vaccine was exposed to 1 F for 3 hours. No adverse symptoms reported. This is one of several reports from the same source. Additional information has been requested.
dose 1: sore arm that gradually worsened; dose 1: sore arm that gradually worsened; immediate fatigue; fever; severe headache; nausea; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 25-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration (at the age of 25 years), administered in left arm on 21May2021 at 13:15 as dose 1, single for COVID-19 immunization. The patient medical history included known allergies with latex. Concomitant medications included paracetamol (TYLENOL), ibuprofen (IBUPROFEN) taken for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccinations within 4 weeks. The patient was not tested for covid, post vaccination. It was unknown that the patient had COVID prior vaccination. On 21May2021 at 13:15, the patient experienced dose 1: sore arm that gradually worsened, immediate fatigue, fever, severe headache and nausea. The patient did not receive any treatment for the events. The clinical outcome for all the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Wrong vaccine given for second dose - patient received Moderna first dose, but was not sure and did not have vaccine record card, believed he was due in three weeks from first dose (which was given on 10/05/21), gave pfizer as second dose. Realized wrong vaccine was given when he came back and brought vaccine card to fill out.
Nurse calling to report a temperature excursion involving PROQUAD and VARlVAX.; This spontaneous report was received from a licensed practical nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.   On 27-JAN-2021, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (rHA) (PROQUAD) injection, 0.5 milliliter (ml) (lot number T025510 which has been verified to be valid, expiration date reported and validated as 23-JAN-2022) (vaccination scheme, route of administration, and anatomical site of injection were not reported), and varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (dose, vaccination scheme, route of administration, anatomical site of injection, lot number, and expiration date were not reported) both administered as prophylaxis. The administered doses of the vaccines were stored at a temperature of 8.3 degrees Fahrenheit (F); 8.1 F, during a time frame of 5 minutes, as recorded by a digital data logger. There was no previous temperature excursion.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2101USA013552: US-009507513-2101USA013563: US-009507513-2101USA013565:
sore arm; This is a spontaneous report received from a contactable reporter(s) (nurse). The reporter is the patient.  A 68-year-old female patient received bnt162b2 (bnt162b2), as dose 1, single (batch/lot number: unknown), as dose 2, single (batch/lot number: unknown) and in sep2021 as dose 3 (booster), single (batch/lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: pain in extremity (non-serious), outcome "unknown", described as "sore arm".  Additional information: caller declines to make a report. She doesn't want to get anyone in trouble. Reporter details: caller states she was an lpn 40-year-ago. Caller states she trusts the product and will take vaccines every week so long as she can get on an airplane. States she had dose 1, 2, and 3 and she had a sore arm and came home after the 1st one and it was 90 minutes of go lay down a minute and nothing extreme.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
pain in arm a few hours after receiving injection, the following day had low grade fever 100 and chills that both lasted until 4pm Saturday, nausea, could not lift left arm more than a few inches, extreme fatigue that lasted until 4pm Saturday, red swollen mark on arm by injection site.
HEAVY LEGS, LOSS OF BALANCE, NUMBNESS IN LEGS, CONFUSION, INCONTINENENCE , LOSS OF STRENGTH
Pt reports right after vaccine she developed hives in (R) arm redness in arm & face. Numbness is right arm & around mouth.
Cough  Fatigue  Muscle or body aches  Headache  New loss of taste or smell  Congestion or running nose
Red papular vesicles on trunk and back spreading. Has 25 total, c/o itching.
17 days p/vax pt devel papules & vesicles over arms, trunk;several vesicles > nickel size;had low grade fever;
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. In September 2014, the patient was vaccinated with an improperly stored dose of ZOSTAVAX, (dose, route, lot number and expiration date not reported). No adverse effects were reported. Additional information has been requested.
Patient received vaccine # 2 in her Moderna series on 10/10 and  left the bandage on until it fell of on the morning of 10/13. She developed a red lined rash going up and down her arm and was advised to go to her provider. she was seen and diagnosed with infection
Muscle weakness for 2 months following vaccine Lymph node pain 5 weeks Triggered arthritis and costochondritis for 6-7 weeks Headaches for 2 weeks
Rash occurred on 9/9/00, day after vaccinations were given. Pt is getting better.
Pt after 10 min started to develop dry and itchy throat, she denies difficulty breathing.  She was given one 25mg dose of benadryl and was feeling better.  she had driver with her.
Patient received boostrix immunization on 5/28/19. She states that she started experiencing pain and soreness that evening of the shot, but that it has progressed and she now had numbness in her hand at times. It feels like it is sleeping. She states that she can still use her arm and hand, but there are times when she cannot lift her arm. She is pregnant and is due on 7/25/19; however, she also has preeclampsia and may have her baby before her due date. She spoke with her OB on 6/13/19 and was advised to take tylenol and to apply cold compress. Her OB stated that she could not apply a topical pain relieving gel, such as biofreeze. I advised patient that looking at the literature, there was 1.6% of patients aged
Patient reports had numbness and tingling around mouth and face after a few minutes fi vaccination; Resolved within minutes.  Received second COVIDdose and reports numbness and tingling around lips, mouth, left arm and left leg. Numbness started 24 hours after second dose and continues at this time- 48 hours after 2nd dose.
Positive Covid tests; Positive Covid tests; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EWO217) and as dose 2, single (Lot number: EWO198) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Positive Covid tests". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. The clinical course was reported as follows: "My family and I had positive COVID tests, congestion, cough, fatigue. Some had headaches. Awareness Date : 07Feb2022." No follow-up attempts are possible. No further information is expected.
VOICE CHANGE (CRACKLING), FEVER, LETHARGIC, COUGH
Pt received Influenza Vaccine at 0945 on 26 Nov 07.   9:00pm on 26 Nov 07 the day she received the vaccine she started to feel weak and dizzy, went to bed and slept all night.  At 0645am she got up and started to feel very dizzy.  No vomiting, denies aches, fever. However she does report tiredness and very subtle chills.   She states after lying back down she felt better, but the minute she moves she gets dizzy. It is now 0830 on 27 Nov and pt states the dizziness is a "little bit" there, all the time.  Strongly urged to follow-up with primary care physician.   Follow up phone call at 1130 awakens pt who reports she is not dizzy, but had not been out of bed again.  She reports she is going to call her physicians office for guidance.
This case was reported by an other health professional via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 74-year-old female patient who received SHINGRIX for prophylaxis. On 4th March 2019, the patient received the 1st dose of SHINGRIX. In March 2019, less than a month after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb and injection site rash. In March 2019, the outcome of the extensive swelling of vaccinated limb and injection site rash were recovered/resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb and injection site rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was reported. The physician assistant reported that the patient received their 1st dose of SHINGRIX around 4th March 2019 and had swelling and rash that covered the majority of their arm and lasted for 5 days. The reporter did not know exactly how many hours after the injection the events occurred. The patient received the vaccine at an outside pharmacy, information specific to vaccine, including lot number/expiry date was unknown. The reporter declined to provide patient's date of birth.
Information has been received from a physician concerning a 16 year old female with asthma who on 02-AUG-2007 was vaccinated intramuscularly with her first dose of Gardasil. On 04-OCT-2007 she received her second dose of Gardasil intramuscularly. Concomitant therapy included VENTILAN. The patient was determined to be pregnant on 11-Oct-2007 with a pregnancy test. The patient sought unspecified medical attention in the office. Subsequently the patient experienced vaccine exposure during pregnancy. No problems reported. No further details available. Additional information has been requested. Follow up information received on 11-Dec-2007 from the physician stated that the patient had a spontaneous abortion on 07-Nov-2007, approximately 8 weeks from LMP. The products of conception were examined and described as hemorrhagic necrotic dicidua few syncytiotrophoblastic cells involutengehorioric villi.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age. On 16-JUN-2013, the patient was vaccinated with RECOMBIVAX HB (INJ 10 Y) first dose, second dose on 02-SEP-2013 and third dose on 15-OCT-2003 (dose and route was unknown). The reporter stated that the patient received three doses of RECOMBIVAX HB outside of recommended dosing schedule. No adverse event was reported. No product quality complaint involved. The outcome of the events was unknown. Additional information has been requested.
MUSCLE PAIN IN THE ABDOMINAL AREA; OVERALL DISCOMFORT; TIGHTENING OF THE MUSCLES IN THE MOUTH; STOMACHACHE; WEAKNESS IN WALKING FROM THE HOLDING AREA TO THE PARKING LOT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031) dose was not reported, once a total administered on 12-MAR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced overall discomfort. On 12-MAR-2021, the subject experienced tightening of the muscles in the mouth. On 12-MAR-2021, the subject experienced stomachache. On 12-MAR-2021, the subject experienced weakness in walking from the holding area to the parking lot. On an unspecified date, the subject experienced muscle pain in the abdominal area. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from overall discomfort, tightening of the muscles in the mouth, and weakness in walking from the holding area to the parking lot on 12-MAR-2021, and the outcome of stomachache and muscle pain in the abdominal area was not reported. This report was non-serious.
Initial and follow-up information has been received from a physician and a nurse practitioner, for the Pregnancy Registry for GARDASIL, concerning a 16 year old female who on 12-AUG-2008 was vaccinated with a first dose of GARDASIL (lot number, injection site and route not reported).  The nurse practitioner reported that the patient denied sexual activity and by mistake requested a urine pregnancy test on the patient that came back positive.  The nurse practitioner reported the patient had elected to have an abortion unrelated to the vaccine on 21-AUG-2008.  The nurse practitioner also reported that the patient also had a HIV and Hepatitis test after it was discovered she was pregnant because of the history of baby's father.  Follow-up information was received from the nurse practitioner which reported that the patient did have an elective abortion on 21-AUG-2008.  Upon internal review, elective abortion was determined to be an other important medical event.  Additional information is not expected.
Patient's husband reports that she received the flu shot on 10/25/06. On 10/31/06 went to the ER with severe pain in neck and shoulders with some limited movement to upper extemities.  Pain was the major presenting SX.  Patient's husband reports that patient was given a DX of "pinched nerve" or something like that.  Patient was given Vicodin and Ibuprofen and sent home.  Within 1 to 2 hours after arriving home, patient had complete paralysis.  Patient was able to talk and had no breathing difficulties, but could not move her upper or lower extemities.  Patient was transported to ER via 911 where she remains at the time of this report.  Some improvement has been reported at the time of this writing.  Pt is able to move her L arm and leg. Pt is able to wiggle toes and fingers on the right side.  Pt has no bowel or bladder function. Dx is Transverse Myelitis.  1/2/07 Received medical records from REHAB hosital which reveal patient admitted 11/8/06-11/29/06 with a 3 day history of progressive numbness & weakness of extremities.  Treated w/steroids, PT/OT & antibiotics.  Consults by ID, neuro & PMR PMH: hypothyroidism FINAL DX: cervical cord transverse myelitis; tetroplegia w/Brown Sequard syndrome; hypothyroidism; neurogenic bowel & bladder, resolved; low grade fever; c diff colitis; & strep & yeast UTI, resolved. 2/1/07 Received medical records from first hospital which reveal patient admitted 11/1-11/8/06 after experiencing bilateral arm & leg weakness to the point that she could not walk.  Two days prior to admit, had been helping to move furniture when felt pain in neck spreading to shoulder & weakness into her right arm.  Seen at urgent care center & received pai meds.  When leaving center, legs became weak to the point could not walk.  Ambulance called & taken to ER.   Admit exam revealed right arm strength of 0, left arm movement only from elbow down.  Right leg strength 0 & left leg can flex from knee down.  Having urine & bowel problems requiring enemas & Foley cath. Neuro & neurosurg consults done.  Tx w/5 days of high dose steroids which provided improvement but patient was still unable to walk.  PT/OT started. Transferred to rehab hospital, to f/u w/neuro & neurosurg & to repeat MRI of c spine in 6-8 weeks. FINAL DX: Transverse myelitis with right sided paralysis & left sided weakness; DJD in cervical spine; & history of hypothyroidism.
This patient received a Moderna Bivalent booster vaccine on 11/18/2022 and a 2nd Moderna Bivalent booster on 12/13/2022.
Breakthrough case admission after 2 vaccines Pfizer 8/14/21 lot# FC3181;  PFizer 9/4/21 lot# FC3183
Narratie: PT WAS VACCINATED IN TIMELY MANNER 1/15 AND 2/5/21 WITH PFIZER AND TESTED POSITIVE FOR COVID 8-30-21. PT WAS HOSPITALIZED 9/2/21 AND WAS TREATED FOR HYPOXIA--HE IMPROVED AND WAS DISCHARGED.
I started to have the pain in my back, and it was running down my leg. I've had neuropathy in my foot before and I feared it was that. It got bad enough on November 3rd that I called the doctor's office. I was finally able to see my doctor on Monday, November 8th, and I explained to the Nurse Practitioner what was happening. The plan we made was for me to get some relief with a steroid shot and a pain shot. I was given a card that I have a follow-up appointment in two weeks, after I receive another shot. I have to be hospitalized and put to sleep to receive this other shot for my back pain. I'm receiving the shot on November 15th. I have received this before and it cured my pain, so I am looking forward to receiving that to relieve this back pain I'm feeling. I'm going to receive a message on Friday telling me what time to be at the hospital.
Pt was given flu shot as pharmacy. Age to give shot is 7 and over but she is under 7. No other reaction reported.
Extreme Fatigue and  a few days after the shot, stomach pain (cramplike but not cramps)
Patient complained of a headache after receiving the second Pfizer vaccine. Vitals stable. Given juice, water and crackers. Moved to a safe environment. Continuing to monitor.
Hair falling out in clumps over the last 2 weeks; This is a spontaneous report from a contactable other health care professional, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 at 10:30 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 09:00, the patient experienced hair falling out in clumps and which continued to occur over the last 2 weeks (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event hair falling out in clumps was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
pt recvd 2nd vax 3DEC90 & devel an erythemous papular pruritic rash on left arm. Tx w/ meds & rash remained on upper chest.
raised fever on day 6; arm was sore; Swollen feels like a tennis ball under skin red; Swollen feels like a tennis ball under skin red; Booster; sore under arm and Armpit and side of my Breast; sore under arm and Armpit and side of my Breast; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 10Nov2021 (Lot number: 320301317) at the age of 64 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0171, Location of injection: Arm Left), administration date: 07May2021, when the patient was 64 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0153, Location of injection: Arm Left), administration date: 16Apr2021, when the patient was 64 years old, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 12Nov2021, outcome "not recovered", described as "arm was sore"; SWELLING (non-serious), ERYTHEMA (non-serious) all with onset 12Nov2021, outcome "not recovered" and all described as "Swollen feels like a tennis ball under skin red"; PYREXIA (non-serious) with onset 16Nov2021, outcome "not recovered", described as "raised fever on day 6"; AXILLARY PAIN (non-serious), BREAST PAIN (non-serious) all with onset Nov2021, outcome "not recovered" and all described as "sore under arm and Armpit and side of my Breast"; IMMUNISATION (non-serious) with onset 10Nov2021, outcome "unknown", described as "Booster". Therapeutic measures were not taken as a result of pain in extremity, swelling, erythema, pyrexia, axillary pain, breast pain.  Additional information: clinical course was reported as, 2 days after Booster arm was sore Swollen feels like a tennis ball under skin red and raised fever on day 6, day 7 sore under arm and Armpit and side of my Breast. Facility where the most recent COVID-19 vaccine was administered was pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. List of any other medications the patient received within 2 weeks of vaccination was reported as yes (unspecified). No hospitalization prolonged and no treatment received.  Follow-up attempts are completed. No further information is expected.
10 minutes after vaccination, became itchy and hot all over, felt SOB and panicky. Went to work wellness center where they administered an Epi-pen.  They sent her to the ER where they gave her oral Benadryl and prednisone.  She states she felt fine after that except for some generalized itching.
patient experienced shortness of breath right after vaccination. Patient was seen by EMS and was transported to the ER. EMS  stated  that patient started having signs of a stroke en route to ER.
long term stomach sensitivity /; Diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jun-2021 and was forwarded to Moderna on 28-Jun-2021.    This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL DISCOMFORT (long term stomach sensitivity /) and DIARRHOEA (Diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (long term stomach sensitivity /) and DIARRHOEA (Diarrhea). At the time of the report, ABDOMINAL DISCOMFORT (long term stomach sensitivity /) and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown Treatment information was unknown